Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase <scp>III</scp> randomized, double‐blind, placebo‐controlled trial

Summary Purpose Brivaracetam ( BRV ) is a novel high‐affinity synaptic vesicle protein 2A ligand currently being investigated for the treatment of epilepsy. The purpose of this phase III study was to evaluate the efficacy and safety/tolerability of adjunctive BRV in adults with uncontrolled partial‐...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Victor Biton, Samuel F. Berkovic, Bassel Abou‐Khalil, Michael R. Sperling, Martin Johnson, Sarah Lu
Médium: Artigo
Jazyk:angličtina
Vydáno: 2013
On-line přístup:https://doi.org/10.1111/epi.12433
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/epi.12433
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!